Roxithromycin can treat mycoplasma infections. Roxithromycin is a macrolide antibacterial drug mainly used for Gram-positive bacteria, anaerobic bacteria, chlamydia and mycoplasma infections. Gram-positive bacteria including Staphylococcus aureus, Streptococcus and anaerobic bacteria including Staphylococcus oralis, Streptococcus digestiveis have good sensitivity to roxithromycin. Roxithromycin can penetrate the cell membrane of bacteria and inhibit the synthesis of bacterial proteins to exert antibacterial effects. Roxithromycin is commonly used clinically for the treatment of acute pharyngitis and acute tonsillitis caused by Streptococcus pyogenes, sinusitis, otitis media, acute bronchitis caused by sensitive bacteria, etc. Patients with pneumonia caused by Mycoplasma pneumoniae and Chlamydia also have good results with Roxithromycin. Roxithromycin can also treat urethritis and cervicitis caused by Chlamydia trachomatis, and soft tissue skin infections caused by sensitive bacteria. The main adverse effects of roxithromycin are gastrointestinal reactions, such as abdominal pain, diarrhea and nausea.